NIELSEN HOLDINGS PLC (NLSN) Stock Fundamental Analysis

NYSE:NLSN • GB00BWFY5505

27.98 USD
+0.01 (+0.04%)
At close: Oct 11, 2022
27.99 USD
+0.01 (+0.04%)
After Hours: 10/11/2022, 8:25:24 PM
Fundamental Rating

2

Overall NLSN gets a fundamental rating of 2 out of 10. We evaluated NLSN against 88 industry peers in the Professional Services industry. NLSN may be in some trouble as it scores bad on both profitability and health. NLSN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • NLSN had positive earnings in the past year.
  • In the past year NLSN had a positive cash flow from operations.
NLSN Yearly Net Income VS EBIT VS OCF VS FCFNLSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 500M -500M 1B

1.2 Ratios

Industry RankSector Rank
ROA 4.86%
ROE 15.26%
ROIC 6.42%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NLSN Yearly ROA, ROE, ROICNLSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 10 -10 20 -20

1.3 Margins

  • In the last couple of years the Profit Margin of NLSN has grown nicely.
  • In the last couple of years the Operating Margin of NLSN has grown nicely.
Industry RankSector Rank
OM 23.51%
PM (TTM) 14.99%
GM N/A
OM growth 3Y28.76%
OM growth 5Y6.33%
PM growth 3YN/A
PM growth 5Y43.28%
GM growth 3YN/A
GM growth 5YN/A
NLSN Yearly Profit, Operating, Gross MarginsNLSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 40 60

2

2. Health

2.1 Basic Checks

  • NLSN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for NLSN has been increased compared to 1 year ago.
  • NLSN has a better debt/assets ratio than last year.
NLSN Yearly Shares OutstandingNLSN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 100M 200M 300M
NLSN Yearly Total Debt VS Total AssetsNLSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 5B 10B 15B

2.2 Solvency

  • NLSN has an Altman-Z score of 1.46. This is a bad value and indicates that NLSN is not financially healthy and even has some risk of bankruptcy.
  • The Debt to FCF ratio of NLSN is 8.68, which is on the high side as it means it would take NLSN, 8.68 years of fcf income to pay off all of its debts.
  • NLSN has a Debt/Equity ratio of 1.61. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF 8.68
Altman-Z 1.46
ROIC/WACC0.88
WACC7.27%
NLSN Yearly LT Debt VS Equity VS FCFNLSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2B 4B 6B 8B

2.3 Liquidity

  • NLSN has a Current Ratio of 2.04. This indicates that NLSN is financially healthy and has no problem in meeting its short term obligations.
  • NLSN has a Quick Ratio of 2.04. This indicates that NLSN is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 2.04
NLSN Yearly Current Assets VS Current LiabilitesNLSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

  • NLSN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.15%.
  • Measured over the past years, NLSN shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.84% on average per year.
  • NLSN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -28.72%.
  • NLSN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.12% yearly.
EPS 1Y (TTM)-2.15%
EPS 3Y23.97%
EPS 5Y-6.84%
EPS Q2Q%6.98%
Revenue 1Y (TTM)-28.72%
Revenue growth 3Y-18.71%
Revenue growth 5Y-11.12%
Sales Q2Q%2.44%

3.2 Future

  • Based on estimates for the next years, NLSN will show a small growth in Earnings Per Share. The EPS will grow by 5.62% on average per year.
  • NLSN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.21% yearly.
EPS Next Y6.17%
EPS Next 2Y5.15%
EPS Next 3Y6.05%
EPS Next 5Y5.62%
Revenue Next Year2.38%
Revenue Next 2Y3.15%
Revenue Next 3Y3.41%
Revenue Next 5Y3.21%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NLSN Yearly Revenue VS EstimatesNLSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B
NLSN Yearly EPS VS EstimatesNLSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 15.37, which indicates a correct valuation of NLSN.
  • Compared to an average S&P500 Price/Earnings ratio of 26.64, NLSN is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 13.98, which indicates a correct valuation of NLSN.
  • NLSN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 27.75, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.37
Fwd PE 13.98
NLSN Price Earnings VS Forward Price EarningsNLSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF 15.56
EV/EBITDA 11.18
NLSN Per share dataNLSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.49
PEG (5Y)N/A
EPS Next 2Y5.15%
EPS Next 3Y6.05%

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.86%, NLSN is not a good candidate for dividend investing.
  • Compared to an average S&P500 Dividend Yield of 1.80, NLSN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.86%

5.2 History

  • The dividend of NLSN decreases each year by -44.32%.
  • NLSN has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-44.32%
Div Incr YearsN/A
Div Non Decr YearsN/A
NLSN Yearly Dividends per shareNLSN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • NLSN pays out 16.23% of its income as dividend. This is a sustainable payout ratio.
DP16.23%
EPS Next 2Y5.15%
EPS Next 3Y6.05%
NLSN Yearly Income VS Free CF VS DividendNLSN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 0 500M -500M
NLSN Dividend Payout.NLSN Dividend Payout, showing the Payout Ratio.NLSN Dividend Payout.PayoutRetained Earnings

NIELSEN HOLDINGS PLC

NYSE:NLSN (10/11/2022, 8:25:24 PM)

After market: 27.99 +0.01 (+0.04%)

27.98

+0.01 (+0.04%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)07-27
Earnings (Next)11-04
Inst Owners0.01%
Inst Owner Change0%
Ins Owners10.9%
Ins Owner Change0%
Market Cap10.07B
Revenue(TTM)3.54B
Net Income(TTM)530.00M
Analysts71.43
Price Target28.56 (2.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.86%
Yearly Dividend0.24
Dividend Growth(5Y)-44.32%
DP16.23%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.58%
Min EPS beat(2)6.72%
Max EPS beat(2)10.45%
EPS beat(4)4
Avg EPS beat(4)16.96%
Min EPS beat(4)6.72%
Max EPS beat(4)26.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.28%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)-2.21%
Revenue beat(4)0
Avg Revenue beat(4)-1.93%
Min Revenue beat(4)-2.41%
Max Revenue beat(4)-0.73%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.37
Fwd PE 13.98
P/S 2.85
P/FCF 15.56
P/OCF 10.25
P/B 2.9
P/tB N/A
EV/EBITDA 11.18
EPS(TTM)1.82
EY6.5%
EPS(NY)2
Fwd EY7.15%
FCF(TTM)1.8
FCFY6.43%
OCF(TTM)2.73
OCFY9.75%
SpS9.82
BVpS9.65
TBVpS-15.24
PEG (NY)2.49
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 4.86%
ROE 15.26%
ROCE N/A
ROIC 6.42%
ROICexc N/A
ROICexgc 51.61%
OM 23.51%
PM (TTM) 14.99%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y4.08%
ROICexgc growth 5Y-0.34%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y28.76%
OM growth 5Y6.33%
PM growth 3YN/A
PM growth 5Y43.28%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF 8.68
Debt/EBITDA N/A
Cap/Depr 64.92%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 122.08%
Current Ratio 2.04
Quick Ratio 2.04
Altman-Z 1.46
F-Score6
WACC7.27%
ROIC/WACC0.88
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.15%
EPS 3Y23.97%
EPS 5Y-6.84%
EPS Q2Q%6.98%
EPS Next Y6.17%
EPS Next 2Y5.15%
EPS Next 3Y6.05%
EPS Next 5Y5.62%
Revenue 1Y (TTM)-28.72%
Revenue growth 3Y-18.71%
Revenue growth 5Y-11.12%
Sales Q2Q%2.44%
Revenue Next Year2.38%
Revenue Next 2Y3.15%
Revenue Next 3Y3.41%
Revenue Next 5Y3.21%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.59%
FCF growth 3Y-15.47%
FCF growth 5Y-17.74%
OCF growth 1Y-12.94%
OCF growth 3Y-14.3%
OCF growth 5Y-12.47%

NIELSEN HOLDINGS PLC / NLSN FAQ

What is the ChartMill fundamental rating of NIELSEN HOLDINGS PLC (NLSN) stock?

ChartMill assigns a fundamental rating of 4 / 10 to NLSN.


What is the valuation status for NLSN stock?

ChartMill assigns a valuation rating of 3 / 10 to NIELSEN HOLDINGS PLC (NLSN). This can be considered as Overvalued.


What is the profitability of NLSN stock?

NIELSEN HOLDINGS PLC (NLSN) has a profitability rating of 4 / 10.


How financially healthy is NIELSEN HOLDINGS PLC?

The financial health rating of NIELSEN HOLDINGS PLC (NLSN) is 4 / 10.


What is the earnings growth outlook for NIELSEN HOLDINGS PLC?

The Earnings per Share (EPS) of NIELSEN HOLDINGS PLC (NLSN) is expected to grow by 6.17% in the next year.